| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/09/2005 | US20050123553 Immunogenic for use in diagnosis, vaccination and/or treatment of amyloid fibril disorders such as Alzheimers disease; vaccines |
| 06/09/2005 | US20050123552 Anti-(fibronectin binding site) antibodies, peptides and epitopes that give rise to antibodies that block the binding of fibronectin binding proteins to fibronectin |
| 06/09/2005 | US20050123551 Nucleic acids encoding polypeptides present in normal and neoplastic endometrial cells for use in diagnosis and treatment of endometrial cancer, identifying endometrial tissue; vectors, host cells; vaccines against endometrial cancer |
| 06/09/2005 | US20050123549 E.g. an antibody that binds the CA6 glycotope conjugated to a cytotoxic agent such as a maytansine; kit with instructions for treating cancer and tumors |
| 06/09/2005 | US20050123548 Modified peptides as therapeutic agents |
| 06/09/2005 | US20050123539 administering molecules that block endogenous costimulatory (B7) interactions with cytotoxic t lymphocytes(CTLA4) and/or CD28 antigens |
| 06/09/2005 | US20050123538 nucleotide sequences that code human epidermal growth factor receptors, used for diagnosing and treating cancer |
| 06/09/2005 | US20050123537 Treating cancer and other angiogenic diseases |
| 06/09/2005 | US20050123535 Peptide with amino acid sequences and biologial homologues or derivatives for vaccines or antibodies |
| 06/09/2005 | US20050123534 Humanised antibodies |
| 06/09/2005 | US20050123523 Immunostimulatory nucleic acid molecules |
| 06/09/2005 | US20050123519 nucleotide sequences, expression vectors and host cells, used for increasing the toxicity of insecticidal proteins to mosquitoes |
| 06/09/2005 | US20050123517 Transducing a neuron with a transgene from the pseudotyped retrovirus virion; gene therapy for neurodegenerative diseases; Huntington's, Parkinson's and Alzheimer's Diseases, Amyotrophic Lateral Sclerosis, ataxia, atrophy, prion disease |
| 06/09/2005 | US20050123516 Delivering a neurotrophic formulation comprising a neurotrophin encoding lentiviral expression vector, into one or more delivery sites within a region of the brain containing targeted neurons expressed for therapy of brain disorder |
| 06/09/2005 | US20050123512 Binding agents, vectors, host cells; gene therapy; nucleotide sequence with DNA insert encoding polypeptide; genetic engineering; medical diagnosis |
| 06/09/2005 | US20050123511 vector comprising heterologous nucleic acid molecules that code antigenic polypeptides |
| 06/09/2005 | US20050123508 human granulocyte colony stimulating factor polypeptides having amino acid replacements in the sequence, used for treating hematopoietic, neurological or reproductive disorders |
| 06/09/2005 | DE4142157B4 Opioid-Peptide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzung Opioid peptides, process for their preparation and pharmaceutical composition containing the |
| 06/09/2005 | DE10351471A1 Polyvalente Allergievakzine Polyvalent allergy vaccine |
| 06/09/2005 | CA2547326A1 Novel muscle growth regulator |
| 06/09/2005 | CA2547165A1 Mutated anti-cd22 antibodies and immunoconjugates |
| 06/09/2005 | CA2547140A1 Glycopegylated erythropoietin |
| 06/09/2005 | CA2547126A1 Substance binding human igg fc receptor iib (fcyriib) |
| 06/09/2005 | CA2546665A1 Protein from horn fly saliva that disrupts hemostasis |
| 06/09/2005 | CA2546654A1 Polynucleotides overexpressed in breast cancer cells, compositions and methods for the therapy and diagnosis of breast cancer |
| 06/09/2005 | CA2546619A1 Il-23 and its receptor; related reagents and methods |
| 06/09/2005 | CA2546614A1 Dna participating in hydroxylation of macrolide compound |
| 06/09/2005 | CA2546498A1 Peptide increasing fusiogenic capacity of a gamete |
| 06/09/2005 | CA2546428A1 Compositions and methods for the diagnosis and treatment of tumor |
| 06/09/2005 | CA2546343A1 Methods for purifying pertussis toxin and peptides useful therefor |
| 06/09/2005 | CA2546326A1 Novel agents for the prevention of leishmaniosis |
| 06/09/2005 | CA2546287A1 Reduction of dermal scarring |
| 06/09/2005 | CA2546222A1 Methods and reagents for treating, preventing and diagnosing bunyavirus infection |
| 06/09/2005 | CA2545867A1 Anti-il-20 antibodies and binding partners and methods of using in inflammation |
| 06/09/2005 | CA2545815A1 Adenoviral vectored tnf-a and chemoradiation to treat cancer |
| 06/09/2005 | CA2545553A1 Methods for producing olfactory gpcrs |
| 06/09/2005 | CA2545520A1 Inhibition of stem cell differentiation, enhancement of proliferation and selective induction of apoptosis by wnt factors |
| 06/09/2005 | CA2542546A1 Anti-il-20 receptor antibodies and binding partners and methods of using in inflammation |
| 06/09/2005 | CA2518101A1 Compositions and methods for the treatment of systemic lupus erythematosis |
| 06/08/2005 | EP1538222A1 Oligonucleotides for the detection of salmonella |
| 06/08/2005 | EP1538217A1 Method of screening insulin content enhancer |
| 06/08/2005 | EP1538210A2 Dna-based vaccination of fish by immersion |
| 06/08/2005 | EP1538209A2 Self-assembling recombinant hpv16 papillomavirus capsid proteins |
| 06/08/2005 | EP1538208A2 Mutants of streptococcal toxin A and methods of use |
| 06/08/2005 | EP1538202A2 Production of human alpha-galactosidase A |
| 06/08/2005 | EP1538199A1 Pituitary differentiation factor and methods of use thereof |
| 06/08/2005 | EP1538196A1 Fibrin-containing composition |
| 06/08/2005 | EP1538164A1 RGD targeting moiety its production and use |
| 06/08/2005 | EP1538163A2 Phosphorylated Amyloid-Beta 1-43 Protein and its use in the treatment of Alzheimer's disease |
| 06/08/2005 | EP1538162A2 Compositions for altering mucus secretion |
| 06/08/2005 | EP1538161A2 32 human secreted proteins |
| 06/08/2005 | EP1538157A2 Isolation and use of SH3 binding peptides |
| 06/08/2005 | EP1538151A1 Artificial oxygen carrier and production method thereof |
| 06/08/2005 | EP1537878A1 Immunopotentiating compositions |
| 06/08/2005 | EP1537417A2 Method of diagnosing colon and gastric cancers |
| 06/08/2005 | EP1537245A2 Dna chips used for bioprocess control |
| 06/08/2005 | EP1537239A2 Methods of identifying compounds that modulate protein activity |
| 06/08/2005 | EP1537237A2 Use of pp2a phosphatase modulators in the treatment of mental disorders |
| 06/08/2005 | EP1537229A2 Methods for producing biological substances in pigment-deficient mutants of bacillus cells |
| 06/08/2005 | EP1537228A2 Modulators of angiogenesis |
| 06/08/2005 | EP1537218A2 Transgenic expression cassettes for expressing nucleic acids in non-reproductive flower tissues of plants |
| 06/08/2005 | EP1537215A2 Zinc-regulated prokaryotic expression cassettes |
| 06/08/2005 | EP1537211A2 Isolated cytokine receptor licr-2 |
| 06/08/2005 | EP1537207A2 Recombinant colstridium neurotoxin fragments |
| 06/08/2005 | EP1537206A2 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 06/08/2005 | EP1537205A2 Viral deconstruction through capsid assembly in vitro |
| 06/08/2005 | EP1537145A1 Pharmaceutical compositions and medical treatments comprising notch ligand proteins |
| 06/08/2005 | EP1537144A1 Method for identifying inhibitors in vivo |
| 06/08/2005 | EP1537143A2 Immunogenic muc1 glycopeptides |
| 06/08/2005 | EP1537142A1 Akap18 delta, a novel splicing variant of a protein kinase a anchor protein and the use of the same |
| 06/08/2005 | EP1537140A2 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer |
| 06/08/2005 | EP1537139A2 A mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanism |
| 06/08/2005 | EP1537138A2 Receptors and membrane-associated proteins |
| 06/08/2005 | EP1537137A2 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 06/08/2005 | EP1537136A2 Promoters for regulation of gene expression in plant roots |
| 06/08/2005 | EP1536834A2 Design of chemokine analogs for the treatment of human diseases |
| 06/08/2005 | EP1536831A2 Pharmaceutical liposomal compositions containing n. meningitidis derived polypeptides or polynucleotides |
| 06/08/2005 | EP1536830A1 Vaccine for respiratory and reproductive system infections in cattle |
| 06/08/2005 | EP1536829A2 Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease |
| 06/08/2005 | EP1536828A2 Methods of delivery of exogenous proteins to the cytosol and uses thereof |
| 06/08/2005 | EP1536821A1 Inhibition of t cell activation by butyrophilin 4 or b7-l1 |
| 06/08/2005 | EP1536818A2 Fibrinogen binding moieties |
| 06/08/2005 | EP1536813A2 Compositions and methods comprising protein activated receptor antagonists |
| 06/08/2005 | EP1536812A2 Methods for modulating activity of the fxr nuclear receptor |
| 06/08/2005 | EP1536808A2 Heterocarpin, a plant-derived protein with anti-cancer properties |
| 06/08/2005 | EP1497469A4 Assay for evaluation of activity of compounds against hcv using a novel detection system in the hcv replicon |
| 06/08/2005 | EP1417311A4 Maize basal layer antimicrobial protein polynucleotides and methods of use |
| 06/08/2005 | EP1206488B1 Method for isolating and purifying grass pollen allergens |
| 06/08/2005 | EP1169441B1 Pharmaceutical compositions for the treatment of heart failure |
| 06/08/2005 | EP1092017A4 Novel gaba-b receptor |
| 06/08/2005 | EP1007654B1 In vitro peptide or protein expression library |
| 06/08/2005 | EP0997152B1 Antibodies as REMEDIES FOR LYMPHOCYTIC TUMORS (EXCEPT MYELOMA) |
| 06/08/2005 | EP0960128B1 Gene product over expressed in cancer cells |
| 06/08/2005 | EP0850252B1 Mutant plasminogen activator-inhibitor type 1 (pai-1) and uses thereof |
| 06/08/2005 | EP0793504B1 Chimeric cytokines and uses thereof |
| 06/08/2005 | EP0777738B1 Condii toxoplasma p30 expression cassette |
| 06/08/2005 | CN1625687A The method for measuring the amount of beta ig-h3 protein and diagnostic kit using the same |
| 06/08/2005 | CN1625598A Methods to culture circovirus |
| 06/08/2005 | CN1625596A Transcriptional factor, transcriptional factor gene, recombinant vector containing transcriptional factor gene, koji-mold transformed by the vector and method of using koji-mold |
| 06/08/2005 | CN1625567A Novel monoclonal antibody and nematode larval antigens |